Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Trinity Bio ADR (TRIB)

Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trinity Bio ADR IDA BUSINESS PARK BRAY WICKLOW L2 A98 H5C8 IRL

www.trinitybiotech.com P: 353-1276-9800 F: 353-127-6988

Description:

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.

Key Statistics

Overview:

Market Capitalization, $K 13,947
Enterprise Value, $K 50,367
Shares Outstanding, K 7,622
Annual Sales, $ 56,830 K
Annual Net Income, $ -24,020 K
Last Quarter Sales, $ 13,430 K
Last Quarter Net Income, $ -5,500 K
EBIT, $ -27,040 K
EBITDA, $ -25,260 K
60-Month Beta 1.21
% of Insider Shareholders 8.20%
% of Institutional Shareholders 78.97%
Float, K 6,997
% Float 91.80%
Short Volume Ratio 0.01

Growth:

1-Year Return -64.81%
3-Year Return -89.36%
5-Year Return -86.79%
5-Year Revenue Growth -41.44%
5-Year Earnings Growth -359.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 04/04/24
Latest Earnings Date 03/28/24
Earnings Per Share ttm -3.38
EPS Growth vs. Prev Qtr 24.44%
EPS Growth vs. Prev Year 24.44%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.220 on 06/05/15
Next Ex-Dividends Date 06/05/15
Dividend Payable Date 07/01/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/23/24

TRIB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -36.02%
Profit Margin % -42.27%
Debt/Equity -1.67
Price/Sales 0.25
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.14
Interest Coverage -2.34

TRIB Dividends

Date Value
06/05/15 $0.2200
06/06/14 $0.2200
06/06/13 $0.2000
06/06/12 $0.1500
06/07/11 $0.1000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar